PT1347765E - Formulacoes dermatologicas - Google Patents

Formulacoes dermatologicas

Info

Publication number: PT1347765E
Authority: PT; Portugal
Prior art keywords: dermatological formulations; clindamycin; rosacea; acne; zinc salt
Prior art date: 2000-11-28

Application number

PT01998353T

Other languages

English (en)

Inventor

Mcdonagh Emma

Kanis Rebecca

Original Assignee

Access Pharma Inc

Strakan Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-28

Filing date

2001-11-28

Publication date

2006-08-31

2001-11-28 Application filed by Access Pharma Inc, Strakan Int Ltd filed Critical Access Pharma Inc

2006-08-31 Publication of PT1347765E publication Critical patent/PT1347765E/pt

Links

239000000203 mixture Substances 0.000 title 1
208000002874 Acne Vulgaris Diseases 0.000 abstract 1
UFUVLHLTWXBHGZ-MGZQPHGTSA-N [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical group CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@@H](SC)O1 UFUVLHLTWXBHGZ-MGZQPHGTSA-N 0.000 abstract 1
206010000496 acne Diseases 0.000 abstract 1
229960002227 clindamycin Drugs 0.000 abstract 1
KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
201000004700 rosacea Diseases 0.000 abstract 1
230000009885 systemic effect Effects 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1
150000003751 zinc Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)

PT01998353T 2000-11-28 2001-11-28 Formulacoes dermatologicas PT1347765E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0029018.9A GB0029018D0 (en)	2000-11-28	2000-11-28	Dermatological formulations

Publications (1)

Publication Number	Publication Date
PT1347765E true PT1347765E (pt)	2006-08-31

Family

ID=9904040

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT01998353T PT1347765E (pt)	2000-11-28	2001-11-28	Formulacoes dermatologicas

Country Status (24)

Country	Link
US (2)	US20040109902A1 (pt)
EP (1)	EP1347765B1 (pt)
JP (1)	JP4272425B2 (pt)
KR (1)	KR100629326B1 (pt)
AT (1)	ATE321560T1 (pt)
AU (2)	AU2309102A (pt)
BR (1)	BR0115727A (pt)
CA (1)	CA2429205C (pt)
CZ (1)	CZ305272B6 (pt)
DE (1)	DE60118441T2 (pt)
DK (1)	DK1347765T3 (pt)
ES (1)	ES2263689T3 (pt)
GB (1)	GB0029018D0 (pt)
HR (1)	HRP20030433B1 (pt)
HU (1)	HUP0400520A3 (pt)
IL (1)	IL152720A0 (pt)
MX (1)	MXPA03004733A (pt)
NZ (1)	NZ526170A (pt)
PL (1)	PL207221B1 (pt)
PT (1)	PT1347765E (pt)
RU (1)	RU2277419C2 (pt)
SK (1)	SK288111B6 (pt)
WO (1)	WO2002043739A2 (pt)
ZA (1)	ZA200305012B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2507070T3 (es)	2006-02-03	2014-10-14	Omp, Inc.	Tratamiento antienvejecimiento utilizando composiciones de cobre y zinc
US7897800B2 (en)	2006-02-03	2011-03-01	Jr Chem, Llc	Chemical compositions and methods of making them
US7687650B2 (en)	2006-02-03	2010-03-30	Jr Chem, Llc	Chemical compositions and methods of making them
US7867522B2 (en)	2006-09-28	2011-01-11	Jr Chem, Llc	Method of wound/burn healing using copper-zinc compositions
MX2010005786A (es) *	2007-11-30	2010-06-09	Novartis Ag	Bisfosfonatos de alquilo de 2 a 5 atomos de carbono-imidazol.
US8273791B2 (en)	2008-01-04	2012-09-25	Jr Chem, Llc	Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (en)	2009-01-23	2010-07-29	Jr Chem, Llc	Rosacea treatments and kits for performing them
CA2719512A1 (en)	2010-11-01	2012-05-01	Stiefel Research Australia Pty Ltd	Polymeric topical compositions
AU2010238566B2 (en) *	2010-11-01	2012-09-20	Stiefel Research Australia Pty Ltd	Polymeric topical compositions
US8952057B2 (en)	2011-01-11	2015-02-10	Jr Chem, Llc	Compositions for anorectal use and methods for treating anorectal disorders
US9023399B2 (en)	2012-11-16	2015-05-05	NU Technology, LLC	Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en)	2013-01-09	2013-12-24	NU Technology, LLC	Dermatological cream with natural ingredients base
CN109498564B (zh) *	2018-12-21	2021-04-16	贵州景峰注射剂有限公司	一种克林霉素磷酸酯配液及其制备方法
US20230000892A1 (en) *	2021-06-30	2023-01-05	Kenneth Okafor	Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3969516A (en) *	1974-12-19	1976-07-13	Nelson Research & Development Company	Composition and method for treatment of acne
US4621075A (en) *	1984-11-28	1986-11-04	The Procter & Gamble Company	Gel-form topical antibiotic compositions
US4895727A (en) *	1985-05-03	1990-01-23	Chemex Pharmaceuticals, Inc.	Pharmaceutical vehicles for exhancing penetration and retention in the skin
JPS6251619A (ja) *	1985-08-30	1987-03-06	Wako Pure Chem Ind Ltd	外用ゲル製剤
TW203552B (en) *	1992-02-18	1993-04-11	J Baroody Lloyd	Compositions of clindamycin and benzoyl peroxide for acne treatment
AU703926B2 (en) *	1994-03-28	1999-04-01	Trustees Of Columbia University In The City Of New York, The	Composition for inactivating irritants in fluids
FR2728166A1 (fr) *	1994-12-19	1996-06-21	Oreal	Composition topique contenant un antagoniste de substance p
US5648389A (en) *	1995-10-27	1997-07-15	Medicis Pharmaceutical, Inc.	Compositions for the treatment of dermatological disorders and methods for their use

2000
- 2000-11-28 GB GBGB0029018.9A patent/GB0029018D0/en not_active Ceased
2001
- 2001-11-28 WO PCT/GB2001/005257 patent/WO2002043739A2/en not_active Ceased
- 2001-11-28 MX MXPA03004733A patent/MXPA03004733A/es active IP Right Grant
- 2001-11-28 NZ NZ526170A patent/NZ526170A/en unknown
- 2001-11-28 EP EP01998353A patent/EP1347765B1/en not_active Expired - Lifetime
- 2001-11-28 PL PL362279A patent/PL207221B1/pl unknown
- 2001-11-28 DK DK01998353T patent/DK1347765T3/da active
- 2001-11-28 AT AT01998353T patent/ATE321560T1/de active
- 2001-11-28 HR HR20030433A patent/HRP20030433B1/xx not_active IP Right Cessation
- 2001-11-28 AU AU2309102A patent/AU2309102A/xx active Pending
- 2001-11-28 PT PT01998353T patent/PT1347765E/pt unknown
- 2001-11-28 JP JP2002545709A patent/JP4272425B2/ja not_active Expired - Lifetime
- 2001-11-28 SK SK632-2003A patent/SK288111B6/sk not_active IP Right Cessation
- 2001-11-28 DE DE60118441T patent/DE60118441T2/de not_active Expired - Lifetime
- 2001-11-28 RU RU2003119158/15A patent/RU2277419C2/ru not_active IP Right Cessation
- 2001-11-28 IL IL15272001A patent/IL152720A0/xx active IP Right Grant
- 2001-11-28 HU HU0400520A patent/HUP0400520A3/hu unknown
- 2001-11-28 CA CA2429205A patent/CA2429205C/en not_active Expired - Fee Related
- 2001-11-28 KR KR1020027013077A patent/KR100629326B1/ko not_active Expired - Fee Related
- 2001-11-28 CZ CZ2003-1491A patent/CZ305272B6/cs not_active IP Right Cessation
- 2001-11-28 AU AU2002223091A patent/AU2002223091B2/en not_active Ceased
- 2001-11-28 US US10/432,848 patent/US20040109902A1/en not_active Abandoned
- 2001-11-28 ES ES01998353T patent/ES2263689T3/es not_active Expired - Lifetime
- 2001-11-28 BR BR0115727-2A patent/BR0115727A/pt not_active IP Right Cessation
2003
- 2003-06-26 ZA ZA2003/05012A patent/ZA200305012B/en unknown
2009
- 2009-10-06 US US12/574,052 patent/US8268790B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2002223091B2 (en)	2006-08-31
HUP0400520A3 (en)	2012-08-28
ATE321560T1 (de)	2006-04-15
CA2429205A1 (en)	2002-06-06
WO2002043739A2 (en)	2002-06-06
CA2429205C (en)	2010-11-16
NZ526170A (en)	2006-01-27
CZ20031491A3 (cs)	2004-01-14
KR20030069793A (ko)	2003-08-27
DE60118441T2 (de)	2006-11-16
JP2004517829A (ja)	2004-06-17
US20040109902A1 (en)	2004-06-10
HK1059218A1 (en)	2004-06-25
ES2263689T3 (es)	2006-12-16
US8268790B2 (en)	2012-09-18
JP4272425B2 (ja)	2009-06-03
RU2277419C2 (ru)	2006-06-10
PL207221B1 (pl)	2010-11-30
HRP20030433B1 (hr)	2007-10-31
EP1347765A2 (en)	2003-10-01
ZA200305012B (en)	2005-04-26
IL152720A0 (en)	2003-06-24
BR0115727A (pt)	2003-10-14
EP1347765B1 (en)	2006-03-29
MXPA03004733A (es)	2005-02-14
SK288111B6 (sk)	2013-08-02
WO2002043739A3 (en)	2003-05-01
KR100629326B1 (ko)	2006-09-29
GB0029018D0 (en)	2001-01-10
US20100173855A1 (en)	2010-07-08
HRP20030433A2 (en)	2004-08-31
DK1347765T3 (da)	2006-08-07
PL362279A1 (en)	2004-10-18
AU2309102A (en)	2002-06-11
DE60118441D1 (de)	2006-05-18
CZ305272B6 (cs)	2015-07-15
SK6322003A3 (en)	2003-12-02
HUP0400520A2 (hu)	2004-07-28

Publication	Publication Date	Title
PT1347765E (pt)	2006-08-31	Formulacoes dermatologicas
BRPI0317696B8 (pt)	2021-05-25	composição para branqueamento
DE69900081D1 (de)	2001-05-17	Haut- und/oder Haardepigmentierungsmittel
ES2177323T3 (es)	2002-12-01	Preparaciones de insulina concentradas estables para la administracionpor via pulmonar.
DE602004001692D1 (de)	2006-09-14	"No-mix" multiminerale Haarentkräuselungsmitteln
BR0317564A (pt)	2005-11-22	Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
DE60230635D1 (de)	2009-02-12	Körperpflegeprodukte mit elastomeren bereichen, welche einen antimikrobiellen wirkstoff enthalten
ATE418761T1 (de)	2009-01-15	Winkelähnlichkeitsoperator mit verallgemeinertem lensing
WO2003032941A3 (de)	2004-07-08	Kosmetische und/oder dermatologische wirkstoffkombination
BR0113925A (pt)	2003-07-01	Derivados de ácido 2-amino-2-alquil-5 heptenóico e heptinóico úteis como inibidores da sintase de óxido nìtrico
ATE319729T1 (de)	2006-03-15	9a-azalide mit entzündungshemmender wirkung
ATE256392T1 (de)	2004-01-15	Verwendung von polyaminosäurederivate als konservierungsmittel
WO2001072264A3 (de)	2002-02-14	Pro-liposomal verkapselte zubereitungen (iv)
DE60216077D1 (de)	2006-12-28	Topisches produkt mit visuellem indikator
WO2004009038A3 (de)	2004-05-06	Kosmetische zubereitungen mit antibakteriellen eigenschaften glyzyrrhetinsäure enthaltend
BR9903750B1 (pt)	2011-12-13	utilização não terapêutica de pelo menos um extrato de rosácea do gênero sanguisorba e processo cosmético de pigmentação da pele.
ES2124983T5 (es)	2003-11-16	Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
WO2001062208A3 (de)	2001-12-27	Topische kosmetische mittel enthaltend 2-hydrazino-1,3-heteroazole
BR0111485A (pt)	2004-01-06	Anti-oxidante e preparações para a pele para uso externo
AR046634A1 (es)	2005-12-14	Una suspension fungicida acuosa concentrada
FR2808195B1 (fr)	2006-12-08	Patch cosmetique ou dermatologique lyophilise
AR034554A1 (es)	2004-03-03	Un metodo para mejorar la distribucion de un ingrediente activo en un licor de curtido, una tableta o bloque para ser usado en dicho metodo, y el uso de dicha tableta o bloque en el curtido de cuero
DE50111407D1 (de)	2006-12-21	Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
AU2002366530A1 (en)	2003-06-23	Utilization of dihydropinosylvin and derivatives thereof as tyrosinase inhibitors for skin lightening or as antimicrobial substances for preservation or for the treatment of acne, dandruff or body odors
DE60144383D1 (de)	2011-05-19	Methoden zur verminderung oder verhinderung von schmerzen mit spicamycin-derivaten